Authors: von Mehren, M Arlen, P Gulley, J Rogatko, A Cooper, HS Meropol, NJ Alpaugh, RK Davey, M McLaughlin, S Beard, MT Tsang, KY Schlom, J Weiner, LM

Citation: M. Von Mehren et al., The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma, CLIN CANC R, 7(5), 2001, pp. 1181-1191

Authors: Adams, GP Schier, R McCall, AM Simmons, HH Horak, EM Alpaugh, RK Marks, JD Weiner, LM

Citation: Gp. Adams et al., High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules, CANCER RES, 61(12), 2001, pp. 4750-4755

Authors: Amoroso, AR Alpaugh, RK Barth, MW McCall, AM Weiner, LM

Citation: Ar. Amoroso et al., Production and characterization of mice transgenic for the A and B isoforms of human Fc gamma RIII, CANCER IMMU, 48(8), 1999, pp. 443-455

Authors: Alpaugh, RK von Mehren, M Palazzo, I Atkins, MB Sparano, JA Schuchter, L Weiner, LM Dutcher, JP

Citation: Rk. Alpaugh et al., Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon, MED ONCOL, 15(3), 1998, pp. 191-198